The treatment of Eye Health & Glaucoma with vitamins

Eye Health and Glaucoma: Mitamins custom make quality formulas for the treatment of Eye Health & Glaucoma with vitamins. A Eye Health & Glaucoma formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Eye Health and Glaucoma

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    200
    mg
    333%
    Vitamin E
    100
    IU
    333%
    Zinc
    10
    mg
    67%
    Alpha Lipoic Acid
    50
    mg
    *
    Lutein
    1000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Bioflavonoid Concentrate
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Green Tea Extract
    50
    mg
    *
    N-Acetyl L-Cysteine
    100
    mg
    *
    L-Arginine
    100
    mg
    *
    Amino Acid Mix
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Eye Health and Glaucoma Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Metastasis Of Human Pancreatic Cancer Driven By Cancer Stem Cell Subpopulation
Scientists have identified a distinct subpopulation of cancer stem cells (CSCs) that is responsible for metastasis of a deadly human pancreatic cancer. The research, published by Cell Press in the September issue of the journal Cell Stem Cell, provides insight into the role of CSCs in cancer initiation, progression, and metastasis and suggests new directions for development of more effective therapeutics.
Progen Announces PI-88 Phase 2 Lung Cancer Results
Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) announced that the Phase 2 trial administering 250mg of PI-88 in combination with the chemotherapeutic agent docetaxel to patients with advanced non small cell lung cancer did not meet its primary endpoint of significantly improving the progression-free rate at six months compared to docetaxel alone.
This information concerning the support of Eye Health and Glaucoma treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments